Over the trailing 12 months, BLTE insiders sold $40.39 million worth of shares in open-market trades, with no open-market purchases.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Yu-Hsin Lin | Chief Executive Officer | 258,083 | 0 | 258,083 | 49.1% | 30 Oct, 2026 |
| 2 | Hao-Yuan Chuang | Chief Financial Officer | 206,302 | 0 | 206,302 | 39.3% | 30 Oct, 2026 |
| 3 | Wan-Shan Chen | Director | 46,355 | 0 | 46,355 | 8.8% | 30 Oct, 2026 |
| 4 | Hendrik Peter Scholl | Chief Medical Officer | 0 | 14,500 | 14,500 | 2.8% | 05 Oct, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 29 Oct, 2026 | Yu-Hsin Lin | Chief Executive Officer | Acquired J | 5,000 | $0.00 | $0 | 187,949 | Direct |
| 29 Oct, 2026 | Hao-Yuan Chuang | Chief Financial Officer | Acquired J | 5,000 | $0.00 | $0 | 180,264 | Direct |
| 24 Sep, 2026 | Wan-Shan Chen | Director | Acquired X | 13,796 | $0.44 | $6.05K | 37,259 | Direct |
| 24 Sep, 2026 | Wan-Shan Chen | Director | Disposed X | 13,796 | $0.00 | $0 | 0 | Direct |
| 01 Oct, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 200 | $163.63 | $32.73K | 14,800 | Indirect |
| 01 Oct, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 24 | $164.64 | $3.95K | 14,776 | Indirect |
| 01 Oct, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 120 | $165.49 | $19.86K | 14,656 | Indirect |
| 01 Oct, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 50 | $166.44 | $8.32K | 14,606 | Indirect |
| 01 Oct, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 78 | $167.59 | $13.07K | 14,528 | Indirect |
| 01 Oct, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 12 | $168.21 | $2.02K | 14,516 | Indirect |
| 01 Oct, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 14 | $169.36 | $2.37K | 14,502 | Indirect |
| 01 Oct, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 2 | $170.02 | $340 | 14,500 | Indirect |
| 04 Sep, 2026 | Yu-Hsin Lin | Chief Executive Officer | Disposed S | 2,635 | $180.29 | $475.07K | 167,934 | Direct |
| 04 Sep, 2026 | Hao-Yuan Chuang | Chief Financial Officer | Disposed S | 1,633 | $180.16 | $294.20K | 91,800 | Direct |
| 04 Sep, 2026 | Yu-Hsin Lin | Chief Executive Officer | Disposed S | 2,587 | $181.24 | $468.88K | 165,347 | Direct |
| 04 Sep, 2026 | Hao-Yuan Chuang | Chief Financial Officer | Disposed S | 2,000 | $181.05 | $362.11K | 89,800 | Direct |
| 04 Sep, 2026 | Hao-Yuan Chuang | Chief Financial Officer | Disposed S | 2,000 | $182.49 | $364.99K | 87,800 | Direct |
| 04 Sep, 2026 | Yu-Hsin Lin | Chief Executive Officer | Disposed S | 3,413 | $182.50 | $622.87K | 161,934 | Direct |
| 04 Sep, 2026 | Yu-Hsin Lin | Chief Executive Officer | Disposed S | 4,955 | $183.30 | $908.23K | 156,979 | Direct |
| 04 Sep, 2026 | Hao-Yuan Chuang | Chief Financial Officer | Disposed S | 3,759 | $183.27 | $688.90K | 84,041 | Direct |